成人ATA与ACR-TIRADS超声风险分层系统在儿童甲状腺结节中的诊断效能:系统评价与荟萃分析
该系统评价与荟萃分析纳入8篇文献共1036个儿童甲状腺结节,评估成人基于的ACR-TIRADS和ATA系统的诊断效能。ACR-TIRADS高危结节(4或5类)汇总敏感度0.84、特异度0.64;ATA高危结节汇总敏感度0.90、特异度0.50。ACR-TIRADS的漏诊恶性率为21.7%、不必要活检率为62.7%,作者认为现有系统在儿童中诊断效能有限,需进一步验证和改进。
要点
- 儿童甲状腺结节应用成人ACR-TIRADS或ATA系统时,高危结节敏感度较高但特异度有限。
- ACR-TIRADS的5类特异度显著高于ATA,但漏诊恶性率和不必要活检率仍较高。
- 建议考虑降低活检尺寸阈值以提高敏感度、减少漏诊恶性。
诊断标准与关键数值
- ACR-TIRADS各类恶性风险:5类59.3%、4类20.7%、3类11.0%、2类6.0%、1类5.5%。
- ACR-TIRADS高危结节(4或5类)汇总敏感度0.84、特异度0.64。
- ATA各类恶性风险:5类55.4%、4类34.2%、3类12.2%、2类7.5%。
- ATA高危结节(4或5类)汇总敏感度0.90、特异度0.50。
- ACR-TIRADS漏诊恶性率21.7%、不必要活检率62.7%;ATA系统信息不足未计算。
临床应用与阅片要点
- 儿童甲状腺结节使用成人风险分层系统时需注意其特异度有限,可能增加不必要活检。
- ACR-TIRADS在儿童中漏诊恶性率较高,阅片时应警惕高危结节的假阴性可能。
- 考虑降低活检尺寸阈值可能有助于提高敏感度、减少漏诊。
局限性
- 纳入研究数量较少(8篇),样本量有限。
- ATA系统的漏诊恶性率和不必要活检率信息不足,无法计算。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic performance of adult-based "American College of Radiology- Thyroid Imaging Reporting And Data System" (ACR-TIRADS) and "American Thyroid Association" (ATA) in the pediatric population.
METHODS: MEDLINE/PubMed, EMBASE, Cochrane Library, and Web of Science databases were searched for articles investigating the diagnostic performance of each stratification system (ACR-TIRADS or ATA) and evaluated them according to three aspects: (a) the risk of malignancy in each category; (b) diagnostic performance using the classic indicators (sensitivity, specificity); and (c) diagnostic performance regarding fine needle aspiration/biopsy recommendation. In addition to pathologic diagnosis, we allowed imaging follow-up as the reference standard for benign nodules.
RESULTS: Eight articles (1036 thyroid nodules) were included. For ACR-TIRADS, the pooled risk of malignancy in category was as follows: category 5 (59.3%); 4 (20.7%); 3 (11.0%); 2 (6.0%), and 1 (5.5%). For nodules of high suspicion of malignancy (category 4 or 5), the pooled sensitivity and specificity were 0.84 and 0.64. For ATA, the pooled risk of malignancy was as follows: category 5 (55.4%); 4 (34.2%); 3 (12.2%); and 2 (7.5%). For nodules of high suspicion of malignancy (category 4 or 5), the pooled sensitivity and specificity were 0.90 and 0.50. For category 5 nodules, the pooled specificity was significantly higher in ACR-TIRADS (p = 0.02). For ACR-TIRADS, the missed malignancy rate was 21.7% and the unnecessary biopsy rate was 62.7%. Information was not sufficient for this calculation with ATA.
CONCLUSIONS: The diagnostic performance of ACR-TIRADS and ATA in the pediatric population was somewhat modest. Large studies are mandatory for further validation and future amendments.
KEY POINTS: • The pooled sensitivity and specificity for highly suspicious nodules (category 4 or 5) for ACR-TIRADS were 0.84 and 0.64, and for ATA were 0.90 and 0.50, respectively. • When applying ACR-TIRADS for children, the pooled missed malignancy rate (21.7%) and unnecessary biopsy rates (62.7%) are still reasonably high. Insufficient information was available to perform these calculations for the ATA system. • Current risk stratification systems, especially ACR-TIRADS, require modification by focusing more on increasing the sensitivity and decreasing the missed malignancy rate. Lowering size cut-off for biopsy would be a reasonable option.
引用
- Kim PH, Yoon HM, Hwang J, et al. Diagnostic performance of adult-based ATA and ACR-TIRADS ultrasound risk stratification systems in pediatric thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2021. PMID: 33864505. doi:10.1007/s00330-021-07908-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。